CVI Holdings’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

CVI Holdings’s Portfolio EUCR Stock Details EUCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-367,552	Closed	-$3.69M	–	727
2022 Q3	$3.69M	Hold	367,552	–	–	0.29%	120
2022 Q2	$3.64M	Hold	367,552	–	–	0.26%	130
2022 Q1	$3.62M	Buy	367,552 +12,552	+4%	+$123K	0.24%	143
2021 Q4	$3.46M	Hold	355,000	–	–	0.23%	146
2021 Q3	$3.47M	Hold	355,000	–	–	0.22%	161
2021 Q2	$3.5M	Hold	355,000	–	–	0.24%	139
2021 Q1	$3.51M	Buy	+355,000	New	+$3.65M	0.24%	135

Other funds holding EUCR

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CVI Holdings's EUCR Position: Q4 2022 in Review

CVI Holdings sold out of Eucrates Biomedical Acquisition Corp. Ordinary Shares (EUCR) in Q4 2022, closing a stake of 367,552 shares — an estimated $3.69M sold.

CVI Holdings first reported a position in EUCR in Q1 2021 and held it in 7 quarters. The position peaked at $3.69M in Q3 2022. 5 funds tracked by Wall St. Rank hold EUCR as of Q4 2022.

CVI Holdings reported no remaining Eucrates Biomedical Acquisition Corp. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 367,552 Eucrates Biomedical Acquisition Corp. Ordinary Shares shares in Q4 2022, an estimated $3.69M.
CVI Holdings first reported a position in Eucrates Biomedical Acquisition Corp. Ordinary Shares in Q1 2021 and held it in 7 quarters.
CVI Holdings's Eucrates Biomedical Acquisition Corp. Ordinary Shares position peaked at $3.69M in Q3 2022.
5 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Ordinary Shares as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.